These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28386750)

  • 21. Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells.
    Lee JS; Lee MS; Oh WK; Sul JY
    Biol Pharm Bull; 2009 Aug; 32(8):1427-32. PubMed ID: 19652385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
    Bessadóttir M; Skúladóttir EÁ; Gowan S; Eccles S; Ögmundsdóttir S; Ogmundsdóttir HM
    Phytomedicine; 2014 Oct; 21(12):1717-24. PubMed ID: 25442282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
    Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
    Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
    Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.
    Sai S; Vares G; Kim EH; Karasawa K; Wang B; Nenoi M; Horimoto Y; Hayashi M
    Mol Cancer; 2015 Sep; 14():166. PubMed ID: 26338199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.
    Schroeder B; Vander Steen T; Espinoza I; Venkatapoorna CMK; Hu Z; Silva FM; Regan K; Cuyàs E; Meng XW; Verdura S; Arbusà A; Schneider PA; Flatten KS; Kemble G; Montero J; Kaufmann SH; Menendez JA; Lupu R
    Cell Death Dis; 2021 Oct; 12(11):977. PubMed ID: 34675185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Her-2-directed systemic delivery of fatty acid synthase (FASN) siRNA with novel liposomal carrier systems in the breast cancer mouse model.
    Khan A; Aljarbou AN; Khan S; Khan MA
    J Drug Target; 2022 Jul; 30(6):634-645. PubMed ID: 35112640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
    Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
    Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
    Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
    PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TROP2 regulates cisplatin sensitivity of triple-negative breast cancer cells by regulating endoplasmic reticulum stress.
    Zhang M; Xu J; Liu Q; Yan X; Li N
    Histol Histopathol; 2024 May; ():18771. PubMed ID: 38884164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Mol Med; 2008 Oct; 22(4):433-9. PubMed ID: 18813848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
    Corominas-Faja B; Vellon L; Cuyàs E; Buxó M; Martin-Castillo B; Serra D; García J; Lupu R; Menendez JA
    Histol Histopathol; 2017 Jul; 32(7):687-698. PubMed ID: 27714708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells.
    Radin D; Lippa A; Patel P; Leonardi D
    Biomed Pharmacother; 2016 Feb; 77():161-6. PubMed ID: 26796280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells.
    Przybytkowski E; Joly E; Nolan CJ; Hardy S; Francoeur AM; Langelier Y; Prentki M
    Biochem Cell Biol; 2007 Jun; 85(3):301-10. PubMed ID: 17612624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
    Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
    Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments.
    Wu X; Qin L; Fako V; Zhang JT
    Adv Biol Regul; 2014 Jan; 54():214-21. PubMed ID: 24080588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
    Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors.
    Vandhana S; Coral K; Jayanthi U; Deepa PR; Krishnakumar S
    Biochim Biophys Acta; 2013 Sep; 1831(9):1458-66. PubMed ID: 23816424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.